Sensorium Therapeutics
Huda Akil serves as the Gardner C. Quarton Distinguished Professor of Neurosciences in the Department of Psychiatry at the University of Michigan Medical School since 1987 and as Co-Director of the Molecular and Behavioral Neuroscience Institute since 1995. Huda Akil is a member of the National Academy of Sciences and has held various leadership roles, including past president of the American College of Neuropsychopharmacology and board member for NARSAD. Huda Akil's service includes membership on the Scientific Advisory Board of the Brain and Behavior Research Foundation and participation in the Institute of Medicine’s Neuroscience Board and Council. Educational qualifications include a PhD in Biological Psychology from UCLA, a postdoctoral degree in Neuroscience from Stanford University, and both a Master's degree in Psycholinguistics and a Bachelor's degree in Psychology from the American University of Beirut.
This person is not in the org chart
This person is not in any offices
Sensorium Therapeutics
Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world.